1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Remedy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial Methotrexate, TNF Inhibitor - Juvenile Idiopathic Arthritis | Phase 4 | Recruiting | Oslo University Hospital | 150 | 2024-10-24 | 2026-10-19 |
Methotrexate (1) · Tumor Necrosis Factor Inhibitors (1)
Norway (1)